Kaneka Corporation
(株)カネカ
2026/08/23 Updated
Market Cap:
$2.3B (¥371.5B)
Stock Price:
$38.90 (¥6,185)
Exchange Rate: 1 USD = ¥158.98
【Kaneka】2026 Financial Results | Sales of ¥8,116.3 billion (0.5% increase)
Kaneka's consolidated sales for the fiscal year ending March 2026 reached ¥8,116.3 billion (up 0.5% YoY), with net income at ¥309.77 billion (up 22.4%), marking a record high. Segment-wise, Medical and Nutrition have performed well. The outlook for 2027 projects sales of ¥8,200 billion, with dividends increasing to 160 yen.
Key Figures
- Sales: ¥811,638 million (YoY +0.5%)
- Net income attributable to owners of the parent: ¥30,977 million (YoY +22.4%)
- Dividends: 160 yen (Fiscal year ending March 2026)
AI要約
Performance Overview
Future Outlook and Impact on Shareholders
This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.
Kaneka Corporation
Company overview · Stock price · Financial data · All IR
